Drug Profile
Tecemotide - Merck
Alternative Names: BLP25 liposomal vaccine; EMD-531444; Emepepimut-S; L-BLP25; LP-BLP-25; ONO-7165; StimuvaxLatest Information Update: 18 Dec 2023
Price :
$50
*
At a glance
- Originator Biomira
- Developer EMD Serono; Merck KGaA; Merck Serono Co Ltd; National Cancer Institute (USA); Oncothyreon; Ono Pharmaceutical
- Class Cancer vaccines; Peptide vaccines; Peptides
- Mechanism of Action Immunostimulants; Mucin 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Breast cancer; Colorectal cancer; Multiple myeloma; Non-small cell lung cancer; Prostate cancer; Rectal cancer